XXII - 22nd Century Group, Inc.
22nd Century Group, Inc. , an agricultural biotechnology company, focuses on tobacco harm reduction, reduced nicotine tobacco, and enhancing health and wellness through plant science for the life science and consumer products industries. It develops very low nicotine content tobacco and cigarette products under the VLN King and VLN Menthol King names; and SPECTRUM research cigarettes for use in independent clinical studies.
- Sector
- Consumer Defensive
- Industry
- Tobacco
- Market Cap
- $99,646
- Beta
- 0.77
- 52-Week Range
- 0.51-301.185
- CEO
- Lawrence D. Firestone
- Employees
- 56
- IPO Date
- Jan 26, 2011
- Exchange
- NASDAQ
XXII Options Snapshot
Options pricing data for XXII is refreshed daily after the close. When listed contracts exist, this page surfaces the latest at-the-money implied volatility, max pain strike, dealer gamma exposure (GEX), and 25-delta skew. Listed contracts and live snapshots appear once the options chain has been published by the exchange for the most recent session.
What This Page Covers
The XXII overview links into per-metric analysis views: max pain, gamma exposure, volatility skew, expected move, options chain, open interest history, and aggregate Greeks. Microstructure data is available on short interest, short volume, fail-to-deliver, and market structure. Corporate data is on fundamentals, earnings, analyst ratings, and insider trading.
Frequently asked XXII overview questions
- What is XXII?
- XXII is the ticker symbol for 22nd Century Group, Inc., a listed security. 22nd Century Group, Inc. , an agricultural biotechnology company, focuses on tobacco harm reduction, reduced nicotine tobacco, and enhancing health and wellness through plant science for the life science and consumer products industries. Listed on NASDAQ. XXII is the equity ticker shown on this page; equity options traders use the security for directional, volatility, and income strategies via the listed options chain.
- What are XXII's key statistics?
- 22nd Century Group, Inc. (XXII) carries a market capitalization of $99,646, beta of 0.77 relative to the broader market, 52-week range of 0.51-301.185. Full income statement, balance sheet, cash flow, and TTM ratio history is on the per-ticker fundamentals page; daily price history and 52-week levels are accessible from the same view. These structural inputs frame how the options market prices implied volatility around earnings windows and capital events.
- What sector or industry does XXII belong to?
- 22nd Century Group, Inc. operates in the Consumer Defensive sector, in the Tobacco industry. Sector classification affects how the ticker correlates with sector ETFs, how it reacts to macro factors like rate moves and commodity prices, and how its options pricing compares to sector peers. Compare XXII's implied volatility and skew against sector benchmarks to gauge whether the options market is pricing single-name or systemic risk relative to the broader peer group.
- How current is the XXII data on this page?
- Options snapshots refresh after each trading session; if no snapshot is currently posted for XXII, it usually reflects low options liquidity or a recently listed name. Company-profile fields (sector, industry, market cap, P/E, IPO date) refresh from the vendor feed nightly. Financials and earnings refresh as 10-K and 10-Q filings are parsed (typically within several business days of the actual report). FINRA microstructure data refreshes on the source's cadence (daily for short volume, bi-monthly for short interest, weekly for the OTC volume file, twice-monthly for SEC FTD).